Monashee Investment Management LLC Castle Biosciences Inc Transaction History

Monashee Investment Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$58.92 - $97.33 $1.47 Million - $2.43 Million	-25,000 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$43.6 - $73.05 $1.09 Million - $1.83 Million	25,000 New	25,000 $1.68 Million
Q3 2020 Nov 13, 2020	SELL	$38.47 - $52.03 $3.85 Million - $5.2 Million	-100,000 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$27.28 - $43.01 $2.73 Million - $4.3 Million	100,000 New	100,000 $3.77 Million

199

25.9M

303K

30.3K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $743M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.